Self-medication is an important pillar of healthcare

Non-alcoholic fatty liver disease (NAFLD), also known as metabolic associated fatty liver disease or MAFLD, is one of the most common liver diseases worldwide. Although NAFLD is associated with metabolic risk factors, up to 40% of patients with NAFLD are not obese but can still be considered metabolically unhealthy. Current treatment recommendations for NAFLD focus on lifestyle interventions (weig ...

Fatigue negatively impacts quality of life even in otherwise healthy individuals. Recent systematic reviews provide mechanistic plausibility for these effects. In addition, a recent study demonstrates that a combination of vitamins, minerals and Panax ginseng root dry extract (G115®) improves various domains of fatigue in real life.

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing worldwide, as are the long-term risks to health of the affected. Alongside changes in lifestyle and diet, pharmacotherapy is the third pillar of treatment of NAFLD. Real-world data provide evidence of the high value of essential phospholipids in NAFLD treatment and the importance of adherence during long-term therapy.

Probiotics are a generally safe treatment option and have been evaluated positively for several conditions by the Cochrane Collaboration. However, they must have adequate compositional quality and be able to persist in the gut to be efficacious and safe.

There are numerous randomized controlled studies showing that the intake of essential phospholipids (EPL) can reduce steatosis and improve liver function parameters. Based on these studies EPL are named in several national guidelines as one recommended treatment for non-alcoholic fatty liver disease (NAFLD). A retrospective analysis of three observational studies has now investigated the extent to ...